Spyre Therapeutics, Inc.SYRENASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank83
3Y CAGR+289.3%
5Y CAGR-0.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+289.3%/yr
Annual compound
5Y CAGR
-0.2%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 37.74% |
| 2024 | 93.11% |
| 2023 | -85.64% |
| 2022 | 0.64% |
| 2021 | 33.97% |
| 2020 | 38.12% |
| 2019 | -14.99% |
| 2018 | -18.31% |
| 2017 | 18.75% |
| 2016 | -124.20% |